Pharmaceutical company
General Healthcare Issues pertaining to Eli Lilly and Company, including but not limited to drug pricing, importation and innovation policies.
HCR - Health Issues
34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
VENN STRATEGIES
1341 G Street NW, 6th Floor, WASHINGTON, DC, 20005, US
AUSTIN TYLER ROBERTS MICHAEL SPIRA SKYLAR BORCHARDT EMILIA DISANTO (Deputy Inspector General, US Department of State; Chief of Staff, Federal Housing Finance Agency Office of Inspector General; Chief Investigative Counsel & Special Counsel, US Senate Committee on Finance)
Deputy Inspector General, US Department of State; Chief of Staff, Federal Housing Finance Agency Office of Inspector General; Chief Investigative Counsel & Special Counsel, US Senate Committee on Finance